These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 31398437

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation.
    Chang RYK, Chen K, Wang J, Wallin M, Britton W, Morales S, Kutter E, Li J, Chan HK.
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158280
    [Abstract] [Full Text] [Related]

  • 4. Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection.
    Chang RY, Wong J, Mathai A, Morales S, Kutter E, Britton W, Li J, Chan HK.
    Eur J Pharm Biopharm; 2017 Dec; 121():1-13. PubMed ID: 28890220
    [Abstract] [Full Text] [Related]

  • 5. Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa.
    Lin Y, Chang RYK, Britton WJ, Morales S, Kutter E, Chan HK.
    Int J Pharm; 2018 Nov 15; 551(1-2):158-165. PubMed ID: 30223075
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Storage stability of inhalable phage powders containing lactose at ambient conditions.
    Chang RYK, Wallin M, Kutter E, Morales S, Britton W, Li J, Chan HK.
    Int J Pharm; 2019 Apr 05; 560():11-18. PubMed ID: 30710661
    [Abstract] [Full Text] [Related]

  • 9. Phage cocktail powder for Pseudomonas aeruginosa respiratory infections.
    Li M, Chang RYK, Lin Y, Morales S, Kutter E, Chan HK.
    Int J Pharm; 2021 Mar 01; 596():120200. PubMed ID: 33486032
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections.
    Yu S, Wang S, Zou P, Chai G, Lin YW, Velkov T, Li J, Pan W, Zhou QT.
    Int J Pharm; 2020 Feb 15; 575():118915. PubMed ID: 31816354
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K, Katona G, Csóka I, Ambrus R.
    J Pharm Biomed Anal; 2018 Jan 30; 148():73-79. PubMed ID: 28965047
    [Abstract] [Full Text] [Related]

  • 15. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
    Yu J, Chan HK, Gengenbach T, Denman JA.
    Eur J Pharm Biopharm; 2017 Oct 30; 119():224-234. PubMed ID: 28655664
    [Abstract] [Full Text] [Related]

  • 16. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L, Sun S, Parumasivam T, Denman JA, Gengenbach T, Tang P, Mao S, Chan HK.
    Eur J Pharm Biopharm; 2016 May 30; 102():132-41. PubMed ID: 26970252
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria.
    Wang J, Kutter JP, Mu H, Moodley A, Yang M.
    Int J Pharm; 2020 Nov 30; 590():119877. PubMed ID: 32927003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.